TAE

PROCEDURE4 trials

Sponsors

Chinese University of Hong Kong, National Cancer Institute, Naples, Shenzhen SiBiono GeneTech Co.,Ltd, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions

Advanced Hepatocellular Carcinoma (HCC)Arterial EmbolizationBleedingCarcinoma, HepatocellularNeuroendocrine TumorsPeptic Ulcer

Phase 2

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

Shenzhen SiBiono GeneTech Co.,LtdAdvanced Hepatocellular Carcinoma (HCC)

Start: 2014-10-31End: 2016-12-31Target: 60Updated: 2015-07-27

Phase 3

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors

TerminatedNCT01755182

National Cancer Institute, NaplesNeuroendocrine Tumors

Start: 2013-07-31End: 2016-03-31Updated: 2016-05-06

Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma

IRCCS Azienda Ospedaliero-Universitaria di BolognaCarcinoma, Hepatocellular

Start: 2019-12-04End: 2022-04-30Target: 154Updated: 2021-03-19

Unknown Phase

Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis

CompletedNCT01142180

Chinese University of Hong KongArterial Embolization, Bleeding, Peptic Ulcer

Start: 2010-01-31End: 2014-07-31Updated: 2018-07-18

Related Papers

Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial

Gut2018-05-2566 citations